logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chang-Ching Lin

National Cheng Kung University
H指数:14
被引数:821

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12]

勘误：“联合抑制CDK4/6和AKT对三阴性乳腺癌的腔内雄激素受体（LAR）亚型具有高度有效性” [604 (2024) 217219 1–12]

Cancer Letters
IF10.1
2025-07-050
PRE
Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L.
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

NF1基因改变与CDK4/6抑制剂耐药在激素受体阳性转移性乳腺癌中的从临床到基础研究的转化分析

eBioMedicine
IF10.8
2025-06-270
PRE
Maxwell R. Lloyd; Rosario Chica-Parrado; Caroline M. Weipert; Todd C. Knepper; Emily L. Podany; Fabiana Napolitano; Dan Ye; Chang-Ching Lin; Yasuaki Uemoto; Jiemin Liao; Claire Wegrzyn; Christine M. Walko; Lianne Y. Ryan; Jennifer C. Keenan; Arielle J. Medford; Shiyuan A. Liu; Gerburg M. Wulf; Katherine K. Clifton; Cynthia X. Ma; Hyo S. Han; Nicole Zhang; Leif W. Ellisen; Aditya Bardia; Carlos L. Arteaga; Ariella B. Hanker; Seth A. Wander
A bedside-to-bench translational analysis demonstrates that NF1 alterations promote CDK4/6 inhibitor (CDK4/6i) resistance in hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Lloyd, Maxwell; Chica-Parrado, M. Rosario; Knepper, Todd; Lin, Chang-Ching; Podany, Emily; Walko, Christine; Napolitano, Fabiana; Weipert, Caroline; Liao, Jiemin; Medford, Arielle; Ryan, Lianne; Keenan, Jennifer; Zhang, Nicole; Liu, Shiyuan; Wulf, Gerburg; Clifton, Katherine; Ma, Cynthia; Han, Hyo; Ellisen, Leif; Bardia, Aditya; Arteaga, Carlos; Hanker, Ariella; Wander, Seth
Tumor immune microenvironment modulates resistance to estrogen suppression in ER plus breast cancer
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya; Gonzalez-Ericsson, Paula; Formisano, Luigi; Guo, Lei; Chica-Parrado, M. Rosario; Lin, Chang-Ching; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer; Fang, Yisheng; Xu, Lin; Balko, Justin; Mills, Gordon; Labrie, Marilyne; Hanker, Ariella; Arteaga, Carlos
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER plus /RB-deficient breast cancer
NATURE COMMUNICATIONS
IF15.7
2024-03-137
OAAI
Lin, Chang-Ching; Chang, Tsung-Cheng; Wang, Yunguan; Guo, Lei; Gao, Yunpeng; Bikorimana, Emmanuel; Lemoff, Andrew; Fang, Yisheng V.; Zhang, He; Zhang, Yanfeng; Ye, Dan; Soria-Bretones, Isabel; Servetto, Alberto; Lee, Kyung-min; Luo, Xuemei; Otto, Joseph J.; Akamatsu, Hiroaki; Napolitano, Fabiana; Mani, Ram; Cescon, David W.; Xu, Lin; Xie, Yang; Mendell, Joshua T.; Hanker, Ariella B.; Arteaga, Carlos L.
Immune cells infiltration and activation are higher in breast cancers resistant to antiestrogen therapy
CANCER RESEARCH
IF16.6
2023-04-040
PRE
Napolitano, Fabiana; Sudhan, Dhivya R.; Wang, Yunguan; Gonzalez-Ericsson, Paula I.; Formisano, Luigi; Lee, Kyung-Min; Lin, Chang-Ching; Chica-Parrado, Maria Rosario; Ma, Hongli; Evans, Nathaniel; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer; Fang, Yisheng V.; Balko, Justin M.; Mills, Gordon B.; Labrie, Marilyne; Hanker, Ariella B.; Arteaga, Carlos L.

研究方向

暂未获取到该数据
A
Ariella B. Hanker
H 指数:26论文数:251被引数:3,755
C
Carlos L. Arteaga
H 指数:123论文数:1,310被引数:5.5万
F
Fabiana Napolitano
H 指数:16论文数:68被引数:1,009
D
Duxin Sun
H 指数:70论文数:451被引数:2.1万
M
Miao‐Chia Lo
H 指数:7论文数:27被引数:493
A
Alberto Servetto
H 指数:23论文数:173被引数:2,220
E
Emmanuel Bikorimana
H 指数:9论文数:93被引数:305
N
Nicholas Stevers
H 指数:14论文数:75被引数:730
K
Kyung‐min Lee
H 指数:28论文数:129被引数:3,557
S
Samantha L. Tinsley
H 指数:6论文数:18被引数:274